About ABIVAX
ABIVAX is a leading clinical stage biotech company focused on becoming a global leader in the discovery, development and commercialisation of anti-viral compounds and human vaccines to treat some of the world’s most important infectious diseases, including HIV/AIDS and Hepatitis B.
Facts about ABIVAX
Facts about ABIVAX
- Founding: 2013
- Focus : Manufacturer
- Employees: 11-50
- Industry : Biotechnology